E7777 9 mcg/kg
E7777-G000-302
Phase 3 small_molecule completed
Quick answer
E7777 9 mcg/kg for Persistent or Recurrent Cutaneous T-Cell Lymphoma is a Phase 3 program (small_molecule) at CITIUS ONCOLOGY, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CITIUS ONCOLOGY, INC.
- Indication
- Persistent or Recurrent Cutaneous T-Cell Lymphoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed